Skip to main content
SpringerLink
Log in

A History of Toxoids

  • Chapter
  • First Online:
History of Vaccine Development

Abstract

Vaccination is the ultimate way to prevent infectious diseases. Many microbial toxins have been isolated, purified, and toxoided to prepare immunizing agents that are well-tolerated and provide long-lasting protection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ajl SJ, Ciegler A, Kadis S, Montie TC, Weinbaum G. Microbial Toxins Vol I-III. New York: Academic Press, 1970–1972

    Google Scholar 

  2. Alouf JE, Fenrenbach FJ, Freer JH, Jeljaszewicz J. Bacterial Protein Toxins. London: Academic Press, 1984

    Google Scholar 

  3. Falmage P, Alouf JE, Fenrenbach FJ, Freer JH, Jeljaszewicz J, Thelestam M. Bacterial Protein Toxins. Stuttgart: Gustav Fisher, 1986

    Google Scholar 

  4. Germanier RG. Bacterial Vaccine. Orlando: Academic Press, 1964

    Google Scholar 

  5. Harshman S. Microbial Toxins: Tools in Enzymology, Methods in Enzymology, vol 165. San Diego: Academic Press, 1988

    Google Scholar 

  6. Woodrow GC, Levine MM. New Generation Vaccines. New York: Marcel Dekker, 1990

    Google Scholar 

  7. Singh H, Bhatia R. Vaccines, Prospects and Perspectives. Delhi: Forward Publishing Company, 1993

    Google Scholar 

  8. Plotkin SA, Mortimer EA. Vaccines.Philadelphia: WB Saunders Comp, 1994

    Google Scholar 

  9. CDC. Diphtheria epidemic – new independent states of the former Soviet Union, 1990–1994. MMWR 1995;44:17–81

    Google Scholar 

  10. Maurice J. Diphtérie: L’épidémie se léve à l’Est. J Int Med 1955;343:12–13

    Google Scholar 

  11. Relyveld EH, Huet M, Lery L. Passive haemagglutination tests using purified antigens covalently coupled to turkey erythrocytes. Dev Biol Stand 1995;86:225–41

    Google Scholar 

  12. Vincent-Ballereau F, Schrive I, Fisch A et al. La population adulte française est-elle protégée de la diphtérie en 1995. Résultats d’une equête sérologique multricentrique. Méd Mal Infect 1995;25:622–6

    Google Scholar 

  13. OMS. Global immunization of children once again on the rise, saving 3 million lives annually. Press Release WHO/73; 3 October 1995

    Google Scholar 

  14. Klebs E. Ueber Diptheria. Verh Deutsch Kongr Inn Med 1883;2:139–54

    Google Scholar 

  15. Loeffler F. Untersuchungen über die Bedeutung der Mikroorganismem für die Entsthung der Diptherie beim Menschen, bei der Taube and beim Kalbe. Mitt Klin Gesund Berlin 1884,2:629–61

    Google Scholar 

  16. Roux E, Yersin A. Contribution à l’étude de la diphtérie. Ann Inst Pasteur 1888;2:421–99

    Google Scholar 

  17. Behring von E, Kitasato S. Ueber das Zustandekekommen de Diphtherie – Immunität und der Tetanus – Immunität bei Tieren. Dtsch Med Wschr 1890;16:1113–4

    Article  Google Scholar 

  18. Behring von E. Untersuchungen über das Zustandekekommen de Diphtherie - Immunität bei Tieren. Dtsch Med Wschr 1890;16:1145–8

    Article  Google Scholar 

  19. Smith TH. The degree and duration of passive immunity to diphtheria toxin transmitted by immunized females guinea-pigs to their offspring. J Med Res 1907;16:359–79

    PubMed  CAS  Google Scholar 

  20. Smith TH. Active immunity produced by so-called balanced or neutral mixtures of diphtheria toxin and anti-toxin. J Exp Med 1909;11:241–56

    Article  PubMed  CAS  Google Scholar 

  21. Behring von E. Ueber ein neues Diptherieschützmittel. Dtsch Med Wschr 1913;39:873–6

    Article  Google Scholar 

  22. Schick B. Kutanreaktion bei Impfung mit Diptherietoxin. Münch Med Wschr 1908;55:504–6

    Google Scholar 

  23. Schick B. Die Diptherietoxin – Hautreaktion des Menschen als Vorprobe de prophlaktischen Diptherieheil-seruminjektio. Münch Med Wschr1913;60:2608–10

    Google Scholar 

  24. Relyveld EH, Hénocq E, Raynaud M. Etude de la reaction de Schick à l’aide d’une toxine pure. Bull Acad Méd 1962;146:101–9

    CAS  Google Scholar 

  25. Park WH. Toxin-antitoxin immunization against diphtheria. Amer Med Ass 1922;79:1584–90

    Google Scholar 

  26. Loewenstein E. Euber Immunisierung mit antischen Toxinen und mit übercompensierten Toxin-antitoxin Muschungen bei Diptherie. Z Exp Path Ther 1914;15:279–321

    Article  Google Scholar 

  27. Glenny AT, Hopkins BE. Diphtheria toxoid as an immunizing agent. Brit J Exp Pathol 1923;4:283–8

    CAS  Google Scholar 

  28. Ebisawa I. Three to four instead o one millilitre of formalin. Vaccine 1996;14:247

    Google Scholar 

  29. Ramon G. Sur le pouvoir floculant et sur le propriétés immunisantes d’une toxine diphtérique rendue anatoxique (anatoxine). CR Acad Sci (Paris) 1923;177:1338–40

    Google Scholar 

  30. Nicolaier A. Ueber infectiösen Tetanus. Dtsch Med Wschr 1884;10:842–4

    Article  Google Scholar 

  31. Kitasato S. Ueber den Tetanus bacillus. Z Hyg Infektionskr 1889;7:225–34

    Article  Google Scholar 

  32. Faber K, Die Pathogenie des Tetanus. Berl Klin Woch 1890;27:717–20

    Google Scholar 

  33. Ramon G, Zoeller C. De la valeur antigénique de ;’anatoxine tétanique che l’homme. CR Acad Sci (Paris) 1926;182:245–7

    Google Scholar 

  34. Relyveld EH. Toxine et antitoxine diphthériques – Étude immunologique. Paris: Editions Scientifiques Hermann, 1959

    Google Scholar 

  35. Relyveld EH. Current developments in production and testing of tetanus and diphtheria ­vaccines. In: Mizrahi A, Hertman T, Klungberg MA, Hohn A, eds. New Developments with Human and Veterinary Vaccines. New York Alan R Liss, 1980;51–76

    Google Scholar 

  36. Linggood FV. Purification of diphtheria toxin and toxoid made from tryptic digest broths. Br J Exp Pathol 1941;22:255–61

    CAS  Google Scholar 

  37. WHO (BLG) UNDP(77.1 Rev 1) Manual for the production and control of vaccines; diphtheria toxoid

    Google Scholar 

  38. van Hemert P. Vaccine Production as a Unit Process. Delft: Thesis, 1971

    Google Scholar 

  39. Prévot AR, Boorsma HJ. Répartition d l’azote et métabolisme azoté dan la toxinogénèse tétanique. Ann Inst Pasteur 1939;63:600–10

    Google Scholar 

  40. Mueller JH, Miller PA. Production of tetanal toxin. J Immunol 1945;50:377–84

    Google Scholar 

  41. Mueller JH, Miller PA. Variable factors influencing the production of tetanus toxin. J Bact 1954;67:274–7

    Google Scholar 

  42. Latham WC, Bent DF, Levine L. Tetanus toxin production in the absence of protein. Appl Microbiol 1962;10:146–52

    PubMed  CAS  Google Scholar 

  43. Bizzini B, Turpin A, Raynaud M. Production et purification de la toxine tétanique. Ann Inst Pasteur 1969;116:686–712

    CAS  Google Scholar 

  44. Neilsen PA. Large scale production of tetanus toxoid. Appl Microbiol 1967;15:453–4

    Google Scholar 

  45. WHO (BLG/UND P/77.2 Rev 1) Manual for the production and control of vaccines:tetanus toxoid

    Google Scholar 

  46. Bizzini B. The chemistry of tetanus toxin. In: Veronesi R, ed. Tetanus: Important New Concepts. Amsterdam: Excerpta Medica, 1981:8–17

    Google Scholar 

  47. Bizzini B. Tetanus. In: Germanier R, ed. Bacterial Vaccines. Orlando: Academic Press, 1984;1–36

    Google Scholar 

  48. Pappenheimer AM. Diphtheria. In: Germanier R, ed. Bacterial Vaccines. Orlando: Academic Press, 1984;38–68

    Google Scholar 

  49. Rappouli R. New improved vaccines against diphtheria and tetanus. In: Woodrow CG, Levin MM, eds. New Generation Vaccines. New York: Marcel Dekker, 1990;251–68

    Google Scholar 

  50. Relyveld EH, Hénocq E. Bizzini B. Studies on untoward reactions to diphtheria and tetanus toxoids. Dev Biol Stand 1979;43:33–7

    Google Scholar 

  51. Relyveld EH. Recent developments with vaccines against bacterial protein toxins. In: Alouf JE, Fehrenbach FJ, Freer JH, Jeljaszewicz J, eds. Bacterial Protein Toxins. London: Academic Press, 1948;217–26

    Google Scholar 

  52. Relyveld EH, Raynoud M. Préparation de la toxine depthérique pure cristallisée à partir de cultures en fermentuer. Caractéres de la toxine pure. Ann Inst Pasteur 1964;107:618–37

    Google Scholar 

  53. Relyveld EH. Studies on the detoxification of purified diphtheria toxin. Progr Immunobiol Standard 1969;3:258–63

    CAS  Google Scholar 

  54. Ramon G. Sur la production de l’antitoxine diphtérique. CR Soc Biol 1925;93:508–9

    CAS  Google Scholar 

  55. Ramon G, Descombey P. Sur l’immunisation atiténtique et sur la production de l’antitoxine tétanique CR Soc Biol 1925;93:508–9

    Google Scholar 

  56. Ramon G. Sur la production des antitoxins. CR Acad Sci 1925;181:157–9

    CAS  Google Scholar 

  57. Ramon G. Quarante Années de Recherches et de Travaux. Toulouse: L’Imprimerie Régionale, 1957

    Google Scholar 

  58. Glenny AT, Pope CG, Waddington H, Wallace U. The antigenic value of toxoid precipitated by potassium alum. J Path Bact 1926;29:38–9

    Google Scholar 

  59. Glenny AT, Barr M. Alum-toxoid precipitates as antigens. J Path Bact 1931;34:118

    Google Scholar 

  60. Holt LB. Developments in Diphtheria Prophylaxis. London: Heinemann, 1950

    Google Scholar 

  61. Gupta RK, Rost BE, Relyveld E, Siber GR. Adjuvant properties of aluminum and calcium compouds. In: Powell MF, Newman MJ eds. Vaccine design: The Subunit and Adjuvant Approach. New York: Plenum Press, 1995;229–48

    Google Scholar 

  62. Lindbald EB. Aluminum adjuvants. In: Stewart-Tull DES, ed. The Theory and Practical Application of Adjuvants. Chicester: John Wiley, 1995;21–35

    Google Scholar 

  63. Edelman R, Hardegree MC, Chedid L. Summary of an international symposium on potentiation of the immune response to vaccines. J Infect Dis 1980;141:103–12

    Article  PubMed  CAS  Google Scholar 

  64. Food and Drug Administration, Center for Drugs and Biologics. Summary Minutes Allergenic Products Advisory Committee and Report of Safety Considerations for the Aluminum Component of Alum-Precipitated Allergenic Extracts. CDB, Office of Biologics Research and Review, Biologics Information Staff (NFN-20) FDA, Bethesda, MD 20892, USA 1987

    Google Scholar 

  65. Goto N, Akama K. Histopathological studies of reactions in mice injected with aluminum adsorbed tetanus toxoid. Microb Immunol 1982;26:1121–32

    CAS  Google Scholar 

  66. Gupta RK, Relyveld EH. Adverse reactions after injection of adsorbed diphtheria-pretussis-tetanus (DTP) vaccine are not only due to pertussis organisms or pertussis components in the vaccine. Vaccine 1991;9:699–702

    Article  PubMed  CAS  Google Scholar 

  67. Matuhasi T, Ikegami H. Elevation of levels of IgE antibody to tetanus toxin in idividuals ­vaccinated with diphtheria-pertussis-tetanus vaccine. J Infect Dis 1982;146:290

    Google Scholar 

  68. Nagel JE, White C, Lin MS, Fireman P. IgE sythesis in man. II. Comparison of tetanus and diphtheria IgE antibody in allergic and nonallergic children. J Allergy Clin Immunol 1979;63:308–14

    Google Scholar 

  69. Paulwels R, Bazin H, Platteau B, van der Straeten M. The influence of different adjuvants on the production of IgD and IgE antibodies. Ann Immunol (Inst Pastuer) 1979;130C:49–58

    Google Scholar 

  70. Vassileb TL. Aluminum phosphate but not calcium phosphate stimulates the specific IgE response in guinea-pigs to tetanus toxoid. Allergy 1978;33:155–9

    Article  Google Scholar 

  71. Nagel JE, White C, Lin MS, Fireman P. IgE sythesis in man. II. Comparison of tetanus and diphtheria IgE antibody in allergic and nonallergic children. J Allergy Clin Immunol 1979;63:608–14

    Google Scholar 

Download references

Acknowledgements

The author is indebted to Prof. B. Bizzini, Drs. M. Huet and L. Lery for their helpful discussions, to Dr. M.A. Fletcher for his editorial assistance and to C. Raoul and S. Hermann for typing and editing the text.

Author information

Authors and Affiliations

  1. 6 rue du, Sergent Maginot, 75016, Paris, France

    Edgar H. Relyveld

Authors
  1. Edgar H. Relyveld
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. , Emeritus Professor of Pediatrics, University of Pennsylvania, Philadelphia, 19104, Pennsylvania, USA

    Stanley A. Plotkin

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Relyveld, E.H. (2011). A History of Toxoids. In: Plotkin, S. (eds) History of Vaccine Development. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1339-5_8

Download citation

Publish with us

Policies and ethics

Search

Navigation